LungLungMartusewicz-Boros MM, Boros PW, Wiatr E, Kempisty A, Piotrowska-Kownacka D, Roszkowski-S´liz˙ K. Cardiac sar- coidosis: is it more common in men? Lung. 2016;194(1):61-66.Martusewicz-Boros MM, Boros PW, Wiatr E, et al. Cardiac sarcoidosis: is it more common in men...
All hospitals in Poland, except psychiatric and military facilities, are legally required to send discharge data to the Institute. The data are anonymous and include information on hospitalizations with ICD10-code diagnoses, dates of admission and discharge, birth date, sex, and place of residence....
Lung involvement may progress to fibrosis, and frank fibrosis can be readily detected. LGE does not discriminate between active, inflammatory disease and the chronic, fibrotic stage; however, when CMR is used in conjunction with PET imaging, staging of the disease may be possible, as outlined in...
First, a patient might present with cardiac symptoms consistent with CS without known or clinically apparent extracardiac sarcoidosis on the basis of clinical examination. These patients can be classified as having a clinically isolated CS.9,10 Of note, most of these patients will have evidence of...
Due to the low body of evidence, diagnostic and therapeutic procedures must be adapted to the individual patient situation.Skowasch, D.Univ Klinikum BonnGrohe, C.Evangel Lungenklin Berlin BuchPizarro, C.Der Pneumologe
Source of Support: Nil, Conflict of Interest: None declared.Westney GE, Habib S, Quarshie A. Comorbid illness and chest radiographic severity in African-American sarcoidosis patients. Lung 2007;185:131--7.Westney, G.E.; Habib, S. & Quarshie, A. (2007). Comorbid illnesses and chest ...
Raheel AhmedRoyal Brompton Hosp, Newcastle upon TyneAzeem HassanNottinghamAli HasanHasan AhmadLeedsJoseph OkaforNational Heart and Lung Institute, LondonCaleb CarverNewcastleAyesha JadoonKhadija AmanullahTinley Park, ILLippincott Williams & WilkinsCirculation...
The younger average age of CS patients in comparison to other ICD cohorts warrants the need for further, large-scale, prospective trials with periodic interim follow-ups focused on those with this condition. Keywords: appropriate therapy; cardiac sarcoidosis; implantable cardioverter–defibrillator; ...
However, little is known concerning serum levels of YKL-40 in sarcoidosis patients. Many attempts have been made to find serological biomarkers of disease activity in sarcoidosis, which could help identify patients at risk for irreversible organ damage, for example, lung fibrosis [7]. However, ...